Lv1
50 积分 2024-06-30 加入
Structural characterization of in vivo and in vitro metabolites of bosutinib by LC-MS/MS, in combination with the in silico methodologies for toxicity and metabolism prediction
2天前
求助中
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
16天前
已完结
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury
2个月前
已完结
Comprehensive Chromatographic Analysis of Belumosudil and its Degradation Products: Development, Validation, and In Silico Toxicity Assessment
3个月前
已完结
Identification and Characterization of Belumosudil Degradation Impurities Using the LC–MS/MS Method and Its Validation
3个月前
已完结
Synchronized determination of sacubitril and valsartan with some co‐administered drugs in human plasma via UPLC–MS/MS method using solid‐phase extraction
4个月前
已完结
The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions
4个月前
已完结
Bioanalytical assay for the quantification of rucaparib in rat plasma using UPLC-MS/MS: development, and validation for interaction with myricetin
4个月前
已完结
Investigation of Ponatinib Metabolism and Drug-Drug Interactions with Lycopene and Shikonin in vitro and in vivo
7个月前
已完结
Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women
7个月前
已完结
皖公网安备34019202002308
